Peptide Partners
Retatrutide
Finnrick tested 2 samples of Retatrutide (GLP-1, GIP, and GCGR antagonist) from Peptide Partners between 17 Jul 2025 and 21 Aug 2025. Test scores average over 7, no score below 6, and at least 2 tests warrant a tentative Finnrick Rating of A (Great).
Finnrick Rating™
Tentative Rating
Peptide Partners
Retatrutide
Tested 2 Samples
Last test 21 Aug 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Peptide Partners
Samples are tested in commercial labs
Tests Count
2
Scores
AVGMINMAX
Last
21 Aug 2025
First
17 Jul 2025
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Batch | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 21 Aug 2025 | View | 20mg | 23.5mg | 20.200mg | -14.2% | 99.95% | CD20250708 | No Label / Silver Crimp / Violet Cap | Lab E | Public | |
| 17 Jul 2025 | View | 30mg | (no batch claim) | 30.400mg | +1.3% | 99.95% | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab E | Public | |